SeaStar Medical Files 8-K: Material Agreement & Equity Sales
Ticker: ICUCW · Form: 8-K · Filed: Jul 11, 2024 · CIK: 1831868
| Field | Detail |
|---|---|
| Company | Seastar Medical Holding CORP (ICUCW) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001, $11.50, $10.55, $10.0 m, $13.1875 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-filing
TL;DR
SeaStar Medical signed a big deal and sold some stock, filing the details today.
AI Summary
SeaStar Medical Holding Corp. entered into a material definitive agreement on July 10, 2024. The company also disclosed unregistered sales of equity securities and provided financial statements and exhibits. The filing details SeaStar Medical's corporate actions and financial reporting.
Why It Matters
This 8-K filing signals significant corporate activity for SeaStar Medical, potentially impacting its financial structure and operational agreements.
Risk Assessment
Risk Level: medium — Material definitive agreements and unregistered equity sales can indicate significant corporate changes or financial needs, warranting closer investor scrutiny.
Key Players & Entities
- SeaStar Medical Holding Corp (company) — Registrant
- July 10, 2024 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by SeaStar Medical?
The filing indicates a material definitive agreement was entered into on July 10, 2024, but the specific details of this agreement are not provided in the provided text.
What type of equity securities were sold by SeaStar Medical?
The filing mentions 'Unregistered Sales of Equity Securities' but does not specify the type or amount of securities sold in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on July 10, 2024.
What is SeaStar Medical Holding Corp.'s Standard Industrial Classification (SIC) code?
SeaStar Medical Holding Corp.'s SIC code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
What was SeaStar Medical's former company name?
SeaStar Medical Holding Corp.'s former company name was LMF Acquisition Opportunities Inc.
Filing Stats: 1,561 words · 6 min read · ~5 pages · Grade level 13.1 · Accepted 2024-07-11 16:15:18
Key Financial Figures
- $0.0001 — ich registered Common Stock par value $0.0001 per share ICU The Nasdaq Stock Mark
- $11.50 — sable for one share of Common Stock for $11.50 per share ICUCW The Nasdaq Stock Ma
- $10.55 — ance date and have an exercise price of $10.55 per share. The Company has agreed to re
- $10.0 m — any from the Offering are approximately $10.0 million, before deducting placement agent
- $13.1875 — r the Offering and an exercise price of $13.1875 per share of Common Stock (equal to 125
Filing Documents
- ea0209262-8k_seastar.htm (8-K) — 48KB
- ea020926201ex4-1_seastar.htm (EX-4.1) — 91KB
- ea020926201ex4-2_seastar.htm (EX-4.2) — 91KB
- ea020926201ex5-1_seastar.htm (EX-5.1) — 6KB
- ea020926201ex10-1_seastar.htm (EX-10.1) — 232KB
- ea020926201ex99-1_seastar.htm (EX-99.1) — 13KB
- ea020926201ex99-2_seastar.htm (EX-99.2) — 12KB
- ex5-1_001.jpg (GRAPHIC) — 3KB
- ex99-1_001.jpg (GRAPHIC) — 14KB
- ex99-2_001.jpg (GRAPHIC) — 4KB
- 0001013762-24-000173.txt ( ) — 864KB
- icu-20240710.xsd (EX-101.SCH) — 4KB
- icu-20240710_def.xml (EX-101.DEF) — 26KB
- icu-20240710_lab.xml (EX-101.LAB) — 36KB
- icu-20240710_pre.xml (EX-101.PRE) — 25KB
- ea0209262-8k_seastar_htm.xml (XML) — 6KB
Forward-Looking Statements
Forward-Looking Statements This Current Report contains forward-looking statements, including, without limitation, statements relating to the Company's expectations regarding the use of proceeds from the Offering. These forward-looking statements are based upon the Company's current expectations. Actual results could differ materially from these forward-looking statements as a result of certain factors, including, without limitation, risks and uncertainties related to the satisfaction of customary closing conditions related to the offering, the uncertain research and product development process, and other risks detailed in the Company's filings with the SEC, including the Company's Annual Report on Form 10-K for the year ended December 31, 2023, as amended, and in the prospectus supplement relating to the offering, filed with the SEC on July 11, 2024. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Current Report. The Company undertakes no duty to update such information except as required under applicable law. Item 9.01 Financial Statements and Exhibits. (d) Exhibits 4.1 Form of Common Stock Purchase Warrant 4.2 Form of Placement Agent Warrant 5.1 Opinion of Dorsey & Whitney LLP 10.1 Securities Purchase Agreement 23.1 Consent of Dorsey & Whitney LLP (included in Exhibit 5.1) 99.1 Press Release dated July 10, 2024 99.2 Press Release dated July 11, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SeaStar Medical Holding Corporation Date: July 11, 2024 By: /s/ Eric Schlorff Name: Eric Schlorff Title: Chief Executive Officer 3